T T Lin, K Norris, N H Heppel, G Pratt, J M Allan, D J Allsup, J Bailey, L Cawkwell, R Hills, J W Grimstead, R E Jones, B Britt-Compton, C Fegan, D M Baird, C Pepper. 'Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease'. British Journal of Haematology 167: 214-223 (2014).
E Kashuba, G L Eagle, J Bailey, P Evans, K J Welham, D Allsup, L Cawkwell. 'Proteomic analysis of B-cell receptor signalling pathways in chronic lymphocytic leukaemia reveals a possible role for kininogen'. Journal of Proteomics 91: 478-485 (2013)
V Agarwal, V C Hodgkinson, G L Eagle, L Scaife, M J Lind, L Cawkwell. 'Proteomic (antibody microarray) exploration of the molecular mechanism of action of the specific COX-2 inhibitor DuP 697'. International Journal of Oncology 42:1088-1092 (2013)
V C Hodgkinson, V Agarwal, D ELFadl, J N Fox, P L McManus, T K Mahapatra, P J Kneeshaw, P J Drew, M J Lind, L Cawkwell. 'Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer'. Journal of Proteomics 75: 2745-2752 (2012)
V C Hodgkinson, D ELFadl, V Agarwal, V Garimella, C Russell, E D Long, J N Fox, P L McManus, T K Mahapatra, P J Kneeshaw, P J Drew, M J Lind, L Cawkwell. 'Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID?', Journal of Proteomics 75: 1276-1283 (2012).